ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
WilkensOne
|
22K |
7.9M |
3 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
22K
|
7.9M
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
WilkensOne
|
248 |
71K |
16 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
248
|
71K
|
16
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
WilkensOne
|
248 |
71K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
248
|
71K
|
6
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
WilkensOne
|
248 |
71K |
12 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
248
|
71K
|
12
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
WilkensOne
|
248 |
71K |
11 |
11/08/24 |
11/08/24 |
ASX - By Stock
|
248
|
71K
|
11
|
|
ASX - By Stock
|
ILA |
Re:
Ann: ISLA-101 Phase 2a/b clinical trial progresses
|
|
WilkensOne
|
46 |
9.9K |
3 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
46
|
9.9K
|
3
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Non-binding term sheet signed with BioCryst
|
|
WilkensOne
|
41 |
9.5K |
0 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
41
|
9.5K
|
0
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
WilkensOne
|
978 |
278K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
978
|
278K
|
7
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
WilkensOne
|
978 |
278K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
278K
|
4
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
WilkensOne
|
978 |
278K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
978
|
278K
|
6
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
WilkensOne
|
6 |
1.3K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
6
|
1.3K
|
0
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
WilkensOne
|
38 |
9.5K |
5 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
38
|
9.5K
|
5
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Non-binding term sheet signed with BioCryst
|
|
WilkensOne
|
41 |
9.5K |
0 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
41
|
9.5K
|
0
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
WilkensOne
|
38 |
9.5K |
3 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
38
|
9.5K
|
3
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
WilkensOne
|
107 |
28K |
15 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
28K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
WilkensOne
|
22K |
7.9M |
1 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
1
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
WilkensOne
|
243 |
84K |
7 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
243
|
84K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
WilkensOne
|
22K |
7.9M |
17 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
17
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
WilkensOne
|
22K |
7.9M |
7 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
7
|
|
ASX - By Stock
|
NUZ |
Re:
PAA Chart
|
|
WilkensOne
|
297 |
86K |
12 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
297
|
86K
|
12
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Non-binding term sheet signed with BioCryst
|
|
WilkensOne
|
41 |
9.5K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
41
|
9.5K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
WilkensOne
|
391 |
85K |
0 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
WilkensOne
|
391 |
85K |
1 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
85K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
WilkensOne
|
130 |
39K |
1 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
39K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
WilkensOne
|
130 |
39K |
9 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
130
|
39K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
WilkensOne
|
22K |
7.9M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
22K
|
7.9M
|
3
|
|
ASX - By Stock
|
SRV |
Re:
Ann: Half Yearly Report and Accounts
|
|
WilkensOne
|
22 |
7.5K |
2 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
22
|
7.5K
|
2
|
|
International Markets
|
SP500 |
Re:
BBUS
|
|
WilkensOne
|
14K |
3.9M |
0 |
01/05/20 |
01/05/20 |
International Markets
|
14K
|
3.9M
|
0
|
|
ASX - By Stock
|
XJO |
Re:
Wednesday, 8th April - Eater sell off inbound
|
|
WilkensOne
|
79 |
27K |
2 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
79
|
27K
|
2
|
|